In CML, loss of miR-150 expression has been shown to cause drug resistance [310,311], while it is downregulated in AML and is a critical tumour suppressor in MLL-fusion-induced leukaemogenesis [312]. Here, KMT2A is linked to acute myeloid leukemia.